ASO Visual Abstract: Resectable Pancreatic Cancer with CA19-9 > 500 U/mL—A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy
Titel:
ASO Visual Abstract: Resectable Pancreatic Cancer with CA19-9 > 500 U/mL—A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy